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Summary
Noncovalent interactions are ubiquitous in ternary
systems involving metal ions, DNA/RNA, and proteins
and represent a structural motif for design of selective
inhibitors of biological function. This contribution
shows that small molecules containing platinated pu-
rine nucleobases mimic the natural DNA(RNA)-trypto-
phan recognition interaction of zinc finger peptides,
specifically the C-terminal finger of HIV NCp7 protein.
Interaction with platinum results in Zn ejection from
the peptide accompanied by loss of tertiary structure.
Targeting the NCp7-DNA interaction for drug design
represents a conceptual advance over electrophiles
designed for chemical attack on the zinc finger alone.
These resultsdemonstrate examplesof anewplatinum
structural class targeting specific biological pro-
cesses, distinct from the bifunctional DNA-DNA bind-
ing of cytotoxic agents like cisplatin. The results con-
firm the validity of a chemical biological approach for
metallodrug design for selective ternary DNA(RNA)-
protein interactions.
Introduction
The nucleocapsid NCp7 protein is an attractive target for
antiviral drug design. Retroviral nucleocapsid proteins
(NCps) from all strains of known retroviruses contain
one or more copies of the conserved CCHC zinc finger
or ‘‘knuckle’’ sequence Cys-X2-Cys-X4-His-X4-Cys (X =
variable) [1]. The nucleocapsid protein NCp7 of human
immunodeficiency virus type I (HIV-I) contains two of
these highly conserved zinc finger domains that are nec-
essary for viral replication [2, 3]. NCps contribute to mul-
tiple steps of the viral life cycle, all of which seem to in-
volve binding to single-stranded nucleic acids [4, 5].
NCp7 is known to have a high affinity for single-stranded
nucleic acids [6] and has been shown to be a potent
chaperone for general nucleic acid folding and unfolding
[7]. The protein is required for correct encapsidation and
packaging of viral RNA [8, 9], and in the virion, NCp7 is
thought to stabilize the dimeric RNA genome through
formation of a ribonucleoprotein complex [10].
*Correspondence: npfarrell@vcu.eduStudies in vitro show that NCp7 can activate the retro-
viral RNA dimerization and also enhances the annealing
of the tRNA3
Lys primer to the initiation site of reverse
transcription, suggesting that correct genomic RNA
packaging and reverse transcription depend upon
NCp7 [11, 12]. The participation of the nucleocapsid pro-
tein in multiple steps in the virus life cycle and the relative
rarity of the CCHC motif in cellular proteins make NCp7
an attractive target for antiviral drug design. Such an
approach would be complementary to drugs such as
protease inhibitors and nucleoside analogs aimed at
other targets of the viral life cycle. Zinc fingers are esti-
mated to represent 1% of the human genome—a total
of 4500 C2H2 zinc finger domains from 564 proteins are
recognized, whereas only 17 domains from nine proteins
contain the CCHC zinc knuckle motif [13, 14].
The molecular details of the interaction of the entire
HIV nucleocapsid protein NCp7 (See Figure 1) bound
to the 20 bp SL3 J-RNA recognition element have
been elucidated by NMR spectroscopy [15]. The struc-
ture showed interactions between the guanine bases
of the single-stranded G6-G7-A8-G9 tetraloop involving
stacking and H-bonding interactions of the exposed G7
and G9 residues with Phe and Trp, respectively [15].
The complex formed between the (12–53) NCp7 frag-
ment, encompassing the two Zn knuckles and the short
linking region, and d(ACGCC), a single-stranded deoxy-
nucleotide sequence corresponding to the shortest
NCp7 binding site, showed similar features [16]. The in-
dole ring of the W37 tryptophan residue is inserted be-
tween adjacent C and G bases and stacked on the latter
[16]. An important recognition motif in both structures is
thus the presence of guanine/tryptophan (and/or phe-
nylalanine) stacking interactions. The presence of the
W37 residue has been revealed as a key feature for
molecular recognition from the zinc finger toward oligo-
nucleotides, as surface plasmon resonance and other
experiments have confirmed [17, 18]. The noncovalent
interaction is conserved even for the more complex
SL2 and SL3 domains in the J-recognition element of
the viral genome [15, 19].
In terms of drug development, covalent modification
of the nucleocapsid protein has been achieved by use
of electrophiles [20]. The electrophiles covalently modify
the zinc binding site through cysteine oxidation or alkyl-
ation to thioether, resulting in eventual cleavage of the
Zn-S bond and zinc ejection. Loss of tertiary structure
and nucleic acid binding ability leads to inhibition of
function and prevention of infectivity. An inherent chal-
lenge for all small-molecule electrophiles is selectivity.
Some anti-HIV agents have been described that target
the NCp7 protein without affecting cellular zinc finger
proteins [21]. In general, there is little intrinsic selectivity
in anti-HIV, Zn-ejecting drugs. Thus, a worthwhile ap-
proach is to search for antagonists of the RNA(DNA)-
protein interaction [22]. In this latter respect, the recog-
nition motif of guanine/tryptophan stacking is worthy of
exploitation in design of NCp7 selective agents. Small
molecules containing dual properties of protein-DNA
recognition as well as zinc ejection capacity would
Chemistry & Biology
540Figure 1. Top, Structure of the Entire HIV
Nucleocapsid Protein and Bottom, Platinum
Compounds Used in This Study
Ia, diethylenetriamine(9-ethylguanine)plati-
num(II). Ib, diethylenetriamine(guanosine)-
platinum(II). II, trans-chlorobispyridine(9-
ethylguanine)platinum(II). III, cis-diammine-
bis(guanosine)platinum(II).represent a building block for more selective interaction
and therapeutic intervention.
Recently, we have proposed analogies between plati-
num and alkylating electrophiles and possible biological
implications thereof. Fluorescence quenching experi-
ments showed that the stacking interaction between
nucleic acid bases and l-tryptophan is significantly en-
hanced upon nucleobase coordination to a Pt(II) center
in [Pt(dien)(L)]2+ (where L = 9-Ethylguanine (9-EtGH),
1-Methylcytosine (1-MeCyt), or their nucleotide mono-
phosphate analogs 50-GMP and 50-CMP) [23, 24]. In the
absence of a reactive leaving group, only noncovalent
hydrogen-bonding and stacking interactions need to
be taken into account. The effect mimics the enhance-
ment of p-p stacking interactions to l-tryptophan upon
methylation of purine and pyrimidine nucleic acid bases,
attributable to a lowering in energy for the p-acceptor
LUMO in the methylated nucleobase, thus improving
the acceptor properties toward the p-donor HOMO of
the amino acid [25]. In parallel studies, the interaction
of trans-[PtCl(9-EtGH)(py)2]
+ and the model zinc chelate
[Zn(bme-dach)]2 results in Zn ejection and eventual in-
corporation of Pt into the macrocycle [26]. Intermediate
heterodinuclear thiolate bridged Pt-S-Zn species are
formed. The thiolate ligand binding sites of [Zn(bme-
dach)]2 present a precedent for S-alkylation reactions
in nature, being sufficiently nucleophilic to be readily
alkylated [27].
We therefore wished to extend these findings to a bio-
logically relevant system. This paper reports on model
studies for recognition and fixation of platinum-nucleo-
base complexes on the C-terminal peptide (F2) of the
HIV-NCp7 zinc knuckle. Figure 1 shows the structure
of the nucleocapsid protein and the platinum com-
pounds studied. The C-terminal peptide was chosen
as proof of principle for a number of reasons: the
knuckle contains the tryptophan moiety, and many ob-
servations indicate that the C-terminal Zn site is more re-
active than the N-terminal sequence. The chemical com-
position of a zinc finger core as well as the local protein
environment determine the reactivity of the zinc finger.
Analysis through protein packing and electrostatic
screening of 207 zinc fingers indicated that the C-termi-
nal finger was one of the most reactive sites [28]. Ex-
perimentally, Cys49 is the most reactive cysteine, andtheoretically, S49 is predicted to be the most nucleo-
philic site [28]. The complexes chosen for extensive
study were [Pt(dien)(9-EtGH)]2+ (Ia), [Pt(dien)(50-GMP)]
(Ib), and cis-[Pt(NH3)2(Guanosine)2]
2+ (III) capable of
only noncovalent interactions and in addition, the
trans-[PtCl(9-EtGH)(py)2]
+ (II), containing one substitu-
tion-labile Pt-Cl bond suitable for covalent interactions.
This paper shows that modulation of the [PtCl(L)(L0)(Nu-
cleobase)]+ (L = NH3, L
0 = py, quin, etc., or L = L0 = py,
etc.) structural motif is a viable approach to more effec-
tive and selective inhibitors of the zinc-finger-nucleic
acid interaction and subsequent zinc ejection. Circular
dichroism, fluorescence quenching, and electrospray
ionization mass spectrometry (ESI-MS) were used to ex-
amine both noncovalent and covalent interaction of the
platinum electrophiles with the 18-residue sequence
corresponding to the C-terminal finger of HIV-NCp7.
1D and 2D NMR studies were used to confirm the nature
of the interaction between the peptide and a model oli-
gonucleotide d(TACGCC).
Results
The Zinc Finger-DNA Interaction
The formation of the zinc finger can be monitored by cir-
cular dichroism, ESI-mass spectrometry, and 1HNMR
spectroscopy (Figure 2). The mass spectrum shows
peaks corresponding to the 2+ to 5+ states of the metal-
lopeptide at m/z = 1144.1, 763.1, 572.8, and 458.6 amu,
respectively (Figure 2A). The CD spectrum confirms the
metallation with a red shift of the ellipticity minimum, typ-
ical of zinc-peptide formation (Figure 2B) [29–31]. The 1H
NMRspectrum inD2Oof the F2zinc finger showsadown-
field shift of the histidine protons and sharp signals at
room temperature, indicating a conformationally stable
structure (Figure 2C). Previous reports on the C-terminal
domain had given spectra indicative of conformational
lability [32]. The reasons for the discrepancy are unclear.
The interactions of the 18-residue sequence corre-
sponding to the N-terminal sequence of HIV-NCp7 with
oligonucleotides d(ACGCC) and d(TTTGGTTT) have
been studied by NMR methods [33, 34]. In the former
case, the affinity is significantly less than for the intact
finger [16]. The complementary study of the C-terminal
F2 alone with a suitable oligonucleotide has not been
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Formation of the F2 exhibits changes that can be monitored by ESI-MS (A), circular dichroism (B), and 1H-NMR (C) for the free peptide (bottom)
upon coordination to Zn2+. The chemical shifts for histidine (H44) protons are highlighted in (C) with the arrows.reported. To confirm the basic features of the C-terminal
finger-RNA(DNA) interaction, the binding to the hexanu-
cleotide d(TACGCC) was studied. The sequence was
chosen to compare with previous studies, and the extra
thymine was added to contribute additional stability to
the peptide-oligonucleotide complex, especially given
the presence of a number of lysine residues in the pep-
tide. Addition of d(TACGCG) to the peptide resulted in
a progressive shift of the protein resonances, indicative
of fast exchange. The resonances were assigned from
2D NOESY and COSY data sets. The full list of assigned
chemical shifts is given in Table S1A. For the protein,
three stretches of NH-NH connectivities are present:
from Lys(5)-Glu(9), from Lys(14)-Cys(16), and from
Thr(17)-Glu(18). The daN sequential assignment is pres-
ent from Lys(5)-Glu(9) and from Met(13)-Glu(18). Com-
parison of the NOESY spectra in H2O and D2O allowed
unambiguous assignment of the nonexchangeable aro-
matic H’s of the His and Trp residues, and long-range
NOEs between these two aromatic residues are ob-
served. The aromatic proton resonances of the trypto-
phan residue all show an upfield shift during the titration
(dHd1 0.34 ppm, dH31 0.33 ppm, dHx2 0.38 ppm, dHh2 0.03
ppm, dHx3 1.20 ppm, and dH33 0.64 ppm), indicating elec-
trostatic interactions between the nucleobases and the
tryptophan ring. Another indication for strong interac-
tions between the oligonucleotide and the protein is
the appearance of new NH resonances during the titra-
tion, which can be assigned to oligonucleotide NH’s
(see below) and the progressive sharpening of the origi-
nal broad water signal upon addition of d(TACGCC). This
reduced exchange broadening of NH with the solvent
can be ascribed to protein-oligonucleotide interactions
(i.e., shielding the exchangeable H’s from the solvent
and/or the presence of H-bonding interactions between
the oligonucleotide and the protein).
The 2D NMR data gave a more detailed picture of the
DNA-protein interactions. The full set of NOE restraints
did not allow an unambiguous structure determination,
but the main features of the interaction may be deduced.
Figure 3A shows the region from a NOESY data set con-
taining contacts between base protons from the DNA
hexamer and aromatic protons from the F2 peptide. In
this region, weak crosspeaks are observed between
C3H5 and both W4-Hz3 and W4-H33, while stronger
crosspeaks are observed between one of the exoyclic
NH2 protons of G4 and W4-Hz3. In Figure 3B, crosspeaksare noted between T1H6 and K14-H32 and between A2H2
and K14-Hg1, which clearly indicate that the K14 side
chain is also involved in intermolecular interactions.
Note the presence of close contacts between the thy-
mine and lysine residues seen from the NMR data. As
a result of intermolecular interactions involving C3 and
G4, the sequential assignment is interrupted between
C3 and G4. These results are consistent with destacking
of the cytosine from the nucleic acid single strand, as in-
dicated by the break in connectivity between C3 and G4,
rather than a formal intercalation of the tryptophan ring
between the adjacent C3 and G4 bases. The structure
of the complex formed between NCp10 from Moloney
murine leukemia virus and the pentanucleotide
d(ACGCC) studied by NMR methods showed insertion
of Trp between two successive bases and its stacking
to dG [35].
Zinc Finger Interaction with Platinated Nucleobases.
NonCovalent Interactions
Once the essential nature of the F2-DNA interaction had
been determined, we aimed to mimic this interaction with
small molecules. Addition of the hexanucleotide to F2
caused the quenching of the tryptophan fluorescence
to a large degree, in agreement with previous studies
[36, 37]. Upon incubation of F2 with [Pt(dien)(9-
EtGH)]2+, Ia, the fluorescence intensity also decreased,
and the fluorescence quenching is more effective than
for free nucleobase, as observed previously. Similar en-
hancement is also found for platinated 50-GMP, (Ib,
[Pt(dien)(50-GMP)]). The association constant values
found by using Eadie-Hofstee analysis are 7.5 3 103,
12.43 103, and 60.03 103 M21 for Ia, Ib, and d(TACGCC),
respectively. Interestingly, while there is little difference
in tryptophan binding between the 9-EtGH and 50-GMP
species, the extra phosphate group enhances binding
to the zinc finger (Figure 4). The ribose monophosphate
moiety could be involved in extra recognition features
of the type Lys-phosphate previously reported for the
complex NCp7/ACGCC [16]. While binding is predictably
not as high as for free hexanucleotide, the results indi-
cate that further incremental increases can be achieved
by extending the length of the oligonucleotide chain
bound to Pt.
The zinc finger-DNA interaction is amenable to study
by mass spectrometry [38]. The ESI-MS spectrum of
F2 in the presence of a 1:1 ratio of [Pt(dien)(9-EtGH)]2+
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3+ state of the 1:1 adduct between the peptide and Pt
complex (Figure 5A). MS-MS experiments on the peak
at m/z = 923.47 shows dissociation to reactants and a
minor peak at m/z = 1293.93, corresponding to the 2+
state of a F2/[Pt(dien)] adduct implying loss of 9-EtGH
(Figure 5B).
Interestingly, the ESI-MS of F2 in the presence of free
9-Ethylguanine itself shows the presence of multiple
Figure 3. F2-Oligonucleotide Interaction
Expanded regions from a 200 ms NOESY data set obtained on
d(TACGCC)-NCp7-F2(Zn) (in H2O,D2O [90:10], 298K) showing: (A) in-
termolecular NOE contacts between the aromatic protons of the TRP
residue and C3H5 and G4NH22 of the oligonucleotide. (B) Hbase-H2
0/
H200 connectivities of d(TACGCC). Note the sequential ‘‘break’’ be-
tween C3 and G4, caused by the interaction with the Trp residue. Se-
quential H6/H8,H20/H200 connectivities are observed for T1, G2, and
C3; however, no connectivities are observed from either C3H2
0 or
C3H2
00 to G4H8. The sequential walk resumes for C5 as H20/H200; H6
connectivities are observed for C5 and C6. In addition, intermolecular
connectivities between protons on the K14 side chain and T1 and A2
are shown.adducts with more than one purine associated with the
peptide (Figure S1A). The predominant adducts are the
1:1 (m/z = 1234.47) and 2:1 (m/z = 1324.40), but higher
stoichiometries of 3:1 are also observed. Since only
one aromatic residue (W37) is available for stacking,
the presence of 1:2 and higher ratio adducts suggests
additional extra noncovalent cation-p interactions given
the positively charged lysines (4) and arginine (1) resi-
dues present in F2 [39]. In this regard, cation-p interac-
tions have been found to occur with a higher frequency
than p-p stacking interactions in protein/nucleic acid
base systems [40]. Coordinate bond formation between
the Zn and 9-EtGH forming a five-coordinate complex is
also possible since the F2/9-EtGH specie was observed
when trans-[PtCl(py)2(9-EtGH)]
+ was used (see below).
The observation of multiple adducts may be due to the
gas phase nature of the reactions—in solution, the plati-
nated 9-Ethylguanine interacts more strongly than the
free base with both simple tryptophan and F2 (Figure 4).
In the case of the F2/50-GMP system only the 1:1 ad-
duct was observed (Figure S1B). The presence of 1:1 ad-
ducts between N-AcTrp, as a model of W37 in F2, and
the complex [Pt(dien)(50-GMP)] have also been detected
via ESI-MS (Figure S2), but mass spectra with the hexa-
nucleotide d(TACGCC) were very noisy and were not
pursued at this time.
The CD spectrum of F2 in presence of [Pt(dien)(9-
EtGH)]2+ shows little perturbation of the secondary met-
allopeptide structure (data not shown). A reasonable in-
terpretation of the results then is that adduct formation
has occurred between the F2 and [Pt(dien)(9-EtGH)]+ fa-
cilitated by the p-p stacking between tryptophan and
the platinated purine nucleobase, but this association
does not disrupt the three-dimensional structure of F2
to a significant degree. Covalent interaction on the other
hand proves to have significantly different conse-
quences (vide infra).
The incubation of cis-[Pt(NH3)2(Guo)2]
2+ (Guo, guano-
sine; III) with F2 showed a very small peak at m/z =
1029.40 amu corresponding to association to the 1:1 ad-
duct [Pt(NH3)(Guo)2/F2]
3+. The peak assignment was
supported by comparison of the calculated isotopic dis-
tribution. An MS2 experiment on the peak clearly re-
vealed signals assignable to the free F2 and the platinum
complex, indicating dissociation (Figure S3). The pres-
ence of these species again implies a chemical model
for DNA recognition. The binding is much weaker than
Figure 4. Noncovalent Interaction of Platinum Complexes—Fluo-
rescence
Comparison between association constants determined for Pt-
nucleobase/nucleotide complexes with N-acetyl tryptophan (left)
and F2 (right). Bars represent the mean 6 0.3 3 1023 M21.
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num Complexes—ESI-MS
Full ESI-MS spectrum of the 1:1 incubation
for [Pt(dien)(9-EtGH)] with F2 (A), MS2 from
the species at 923.73 m/z, confirming the as-
signation of the signal to the 1:1 adduct
[[Pt(dien)(9-EtGH)]/F2]3+.that of [Pt(dien)(9-EtGH)]2+, and thus there are distinc-
tions between platinum complex structures in their inter-
actions with zinc fingers. In this case, steric hinderance
of the two cis-oriented purine nucleosides may account
for the weaker binding. Studies of this compound are
also of interest because of its previously reported antivi-
ral activity [41, 42].
Zinc Finger Interaction with Platinated Nucleobases:
Covalent Interaction and Zinc Ejection
To examine the possible covalent attachment of Pt to the
Zn finger, the interaction was studied with trans-[PtCl(9-
EtGH)(py)2]
+, II. This complex has previously been shown
to have a high kinetic preference for sulfur (methionine)
over nitrogen (50-GMP) binding [43]. Further, Zn was
shown to be ejected from model chelates in the presence
of the complex [26]. In the presence of a 1:1 stoichiomet-
ric ratio of II, the ESI-MS spectrum of F2 after 24 hr now
shows a number of peaks (Figure 6). Free 9-EtGH is
observed and, again, a 1:1 adduct of F2 and 9-EtGH is
seen with a peak at 1233.5 (2+ state). Interestingly a
peak corresponding to trans-[Pt(py)2(9-EtGH)2]
2+ is also
seen at m/z of 355.7. A reasonable interpretation of these
results is that formation of a Zn-S-Pt intermediate will
labilize the trans 9-EtGH ligand due to the strong trans
influence of thiolate. Free 9-EtGH may then form the
five-coordinate species with Zn and substitute Cl in II.
The species of interest in the mass spectrum is
firstly that assigned to F2 + [Pt(py)2]: m/z = 1320.1 (2+),
880.5 (+3), and 655.3 (+4). The isotopic distribution isconsistent with a Pt, Zn species (data not shown). As ob-
served previously, the presence of multiple isotopes in
transition metals makes analysis of isotopic distribution
a very useful asset in assigning stoichiometry [26]. The
second major species of interest is that with m/z values
for a 2+, 3+, and 4+ state of 1464.1, 976.5, and 733.3, re-
spectively. This species corresponds to an adduct
([F2(Pt[py]2)2]-Zn). That is, two [Pt(py)]2 units are bound
to the protein with resultant loss of the zinc atom. The
isotopic distribution of this peak is also consistent with
only two Pt atoms and no Zn. Tandem MS/MS of the
733.3 (4+) state showed sequential loss of four pyridine
ligands leading to the observation of 4+ state fragments
with m/z of 712.5, 693.0, 673.2, and 653.5. The corre-
sponding 3+ state peaks at m/z of 949.7, 923.4, 897.0,
and 870.6 were observed as well, and the isotopic distri-
bution of the latter peak (m/z of 870.6) was also consis-
tent with the presence of two Pt atoms (Figure 6B).
Essentially identical behavior was observed with [SP-4-
2]-[PtCl(9-EtGH)(NH3)(quin)]
+ (data not shown) indicating
that this chemistry is a general feature of this class of
compounds. After 7 days incubation, the major species
observed were trans-[Pt(py)2(9-EtGH)2]
2+ (m/z = 355.7),
(F2 + [Pt(py2)]2)
3+ (m/z = 880.5), (F2 + 2[Pt(py)2] - Zn)
3+
(m/z = 976.5), and (F2 + 9-EtGH)2+ (m/z = 1233.5) (see
Figure S4).
The CD spectra of F2 in presence of trans-[PtCl(9-
EtGH)(py)2]
+ is shown in Figure 6C. Monitoring of the
spectrum through time revealed important changes in
the three-dimensional structure of F2 within the first
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Complex
Covalent interaction between F2 and trans-
[PtCl(py)2(9-EtGH)]
+: (A) ESI-MS spectrum
after 24 hr; incubation shows 1:1 adducts
of the platinum complex and F2 (m/z =
1320.1, 880.5, and 655.3), also signals corre-
sponding to two Pt(py)2 units with the free
peptide (m/z = 1464.1, 976.5, and 733.3), in-
dicating loss of the zinc ion; (B) tandem MS/
MS experiments and isotopic distribution of
the signals confirmed the assignation; (C)
CD spectra of F2 undergo a blueshift of the
ellipticity minimum after incubation with 2
eq. trans-[PtCl(py)2(9-EtGH)]
+; after 72 hr,
the spectrum is very similar to the free pep-
tide. Intact F2 is shown as a reference.24 hr. It is clear that the loss of structural feature is consis-
tent with loss of tertiary structure due to Zn elimination.
Discussion
The results presented here suggest that modulation of
the basic [PtCl(L)(L0)(Nucleobase)]+ (L = NH3, L0 = py,
quin, etc., or L = L0 = py, etc.) structural motif is a viable
approach to more effective and selective inhibitors of
the zinc-finger-nucleic acid interaction. The concept
mechanism involving a classic two-step approach: (1)
target recognition through tryptophan interaction and
(2) target fixation or inhibition involving platinum-protein
complexation followed by zinc ejection is shown in
Figure 7A. The proposed chemical mechanism shown
in Figure 7B is reasonable based on previous results
with zinc fingers and with model zinc chelates [26, 28,
46]. Subsequent reactions including incorporation of
platinum into the finger are possible.
The results are of interest for two main reasons. First,
study of metal displacement of zinc from zinc-finger or
zinc-based proteins has probed the potential biomedical
implications involved in incorporation of metals such as
Cd, Hg, Pb, and Ni (usually studied as aquated 2+ ca-
tions) [30, 44]. The reactions of gold thiomalate with the
Sp1 zinc finger [31] and the use of oligonucleotide-teth-
ered cobalt (salen) as a sequence-specific recognition
probe [45] are, in principle, examples of zinc finger inter-
action with functionalized metal complexes. The results
presented here indicate that functionalized platinumcomplexes (in this case the presence of purine nucleo-
bases and the absence or presence of substitution-labile
binding site) display a variety of chemical reactivity on
the Zn-finger site. While the present study demonstrates
the use of Cys3His finger, it would be expected that the
different limiting Zn-finger coordination sites would
also display different chemical reactivity [28] In this con-
text, the reaction between cisplatin and a 31-amino acid
zinc finger sequence (zpp) N-IC1 E E P TC1 R N R T R H L
P L Q F S R T G P LC2P AC2M K A is noteworthy [46]. The
reaction proceeds in a stepwise manner, and complete
deligation of Zn(II) was only observed with two equiva-
lent of cis-DDP [46]. The subscripted residues represent
the four Zn ligands and the sites of the first and second
attachment of platinum, respectively. These results
have been discussed with respect to apoptosis initiated
by direct interaction of the platinum antitumor agent with
zinc finger transcription factors, but it is of interest to
note that two Pt atoms appear necessary before zinc is
lost from the peptide. In the case of F2, the possible sul-
fur binding sites on F2 include the methionine and the
three Zn bound cysteines. It is possible that the first plati-
nation occurs at the methionine site, and this may not
disturb the zinc coordination sphere. The second plati-
nation would then involve a ligand intimately involved
in maintaining the tetrahedral zinc geometry, and loss
of Zn could then occur, as seen in model systems. Evi-
dence for competitive binding of methionine in proteins
rather than cysteine has come from studies of cisplatin
with human serum albumin [47]. The use of trans-DDP
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(A) Proposed concept mechanism of zinc ejection from F2 involving an initial recognition process through noncovalent interactions and a fur-
ther covalent interaction that eventually disrupts the secondary structure in the protein.
(B) A chemical mechanism for zinc ejection using platinum-nucleobase electrophiles. The specific nature of the coordination site for the
[Pt(py)2] unit remains to be determined.to crosslink the zinc finger nucleocapsid protein to HIV-1
RNA has been reported [10], and the specific interactions
are likely to be similar to those described here.
Secondly, these results suggest novel approaches to
targeting the nucleic acid-zinc finger interaction. Most
approaches to NCp7 inhibition have involved alkylation
or oxidation of the cysteine residues, resulting in re-
duced ability to bind zinc and subsequent loss of confor-
mation thereby diminishing or eliminating infectivity [20].
The small organic molecules designed for electrophilic
attack have little or no DNA selectivity, therefore preclud-
ing attack on the protein-DNA interaction. The presence
of an aromatic residue—tryptophan, phenylalanine, and
tyrosine—as a recognition motif for single-stranded DNA
and RNA is a structural handle one can use in inhibitor
design. A study of oligonucleotide affinity for HIV nucle-
ocapsid protein showed that small GT sequences such
as d(GT)4 had high binding affinity, and indeed this prop-
erty has been used as a screen for nucleic acid antago-
nists of NCp7 [48]. The incipient and moderately selec-
tive antiviral activity of trans-[PtCl(Nucleobase)(L)(L0)]+
is worthy of further rational study based on the concept
hypothesis [49].
Significance
This contribution shows that the interaction of small
molecules such as trans-[PtCl(9-EtGH)(py)2]
+ with
the C-terminal zinc finger of HIV-NCp7 protein results
in Zn ejection from the peptide accompanied by loss
of tertiary structure. The nature of the protein-DNA in-
teraction on the C-terminal finger alone with the hexa-
nucleotide d(TACGCT) was examined. The results
confirm the tryptophan-guanine/cytosine recognitionmotif for zinc finger-single-strandedDNA/RNA interac-
tions and may be placed in context with structural ex-
aminations of the N-terminal finger and the intact 2-
zinc finger peptide with similar DNA sequences. The
platinated nucleobase motif of complexes I and II
mimics the DNA-protein stacking interaction. Target-
ing the NCp7-DNA interaction for drug design repre-
sents a conceptual advance over electrophiles de-
signed for chemical attack on the zinc finger alone.
Thus, complex II is a first example of a new chemotype
capable of selective zinc finger attack through target-
ingof the tryptophan/guanine recognition. In a broader
sense, these results demonstrate examples of a new
platinum structural class targeting specific biological
processes, distinct from the bifunctional DNA-DNA
binding of cytotoxic agents like cisplatin. Extension
of this analogy between Me+ and Pt2+ can suggest fur-
ther novel structural motifs capable of expanding the
role of platinum in biology beyond the current para-
digm. An important goal formedicinal inorganic chem-
ists is to manipulate the many intrinsic features of
transition metal complexes—the number and type of
exchangeable ligands, oxidation state of the central
metal ion, coordination number, and stereochemistry
as well as rate of reaction—to design more selective
agents capable of targeting specific biomolecules
and thus eventually capable of exerting a more spe-
cific biological response.
Experimental Procedures
Starting Materials. Preparation of F2
Coordination of the zinc ion to the peptide (34–52) and secondary
structure characterization of the F2 zinc finger were monitored by
Chemistry & Biology
5461H-NMR, ESI-MS, and CD spectroscopy, and the data obtained
were in agreement with reported values in the literature [30, 45].
The C-terminal zinc finger from the retroviral HIV-1 p7 nucleocap-
sid protein (F2, sequence Lys-Gly-Cys-Trp-Lys-Cys-Gly-Lys-Glu-
Gly-His-Gln-Met-Lys-Asp-Cys-Thr-Glu) was purchased from the
Macromolecular Structure Facility of the University of Arizona (Divi-
sion of Biotechnology). The peptide was dissolved in degassed H2O
solution (HPLC-grade, J.T. Baker) and ZnCl2 (1.2 equimolar) was
added in slight excess with respect to the concentration of the
zinc finger. The pH was adjusted to 6.4, and the sample was lyoph-
ilized. The oligonucleotide d(TACGCC) was synthesized with an Ex-
pedite 8909 DNA synthesizer (Perseptive Biosystems) by the cya-
noethyl phosphoramidite method (reagents were from Glen
Research, Sterling, VA).
NMR Spectroscopy
All NMR spectra were acquired at 298 K and pH 6.4 on a Varian Unity
500 MHZ spectrometer at 2.9 mM concentration. 1H NMR chemical
shifts were referenced to internal H2O (4.72 ppm at 298 K) and
31P
NMR data are referenced to trimethyl phosphate (TMP). 2D NMR
data were collected without sample spinning. 2D NOESY data were
recorded in 90% H2O/10% D2O (tmix 100, 200, and 400 ms) and in
D2O (99.99%, tmix 300 ms). The nonexchangeable NOESY spectrum
was recorded by the States/TPPI technique with 512 t1 increments
and a sweep width of 6802.72 Hz. Solvent suppression for the homo-
nuclear 2D measurements in H2O was achieved by the watergate
technique. 512 t1 increments, each with 1024 t2 complex points,
were collected with a SW of 6802.72 Hz. For the TOCSY experiment,
a tmix of 80 ms was used. The 2QF-COSY was measured according to
literature procedures [50]. The 2D heteronuclear 31P-1H correlation
spectra were recorded by the method described [51]. The data
were processed by using the Felix 2.10 software (BioSym Technolo-
gies) with a cosine-bell function before Fourier transformation.
Assignment of Protein and Oligonucleotide Resonances
The protein resonances of the d(TACGCC)-HIVF2 complex were as-
signed according to established procedures [52]. A summary of the
protein assignments is listed in Table S1A. Interesidual NOEs be-
tween the four residues coordinated to the zinc confirm their spatial
proximity. The NH3 protons of Gln(12) can be observed in the TOCSY
from a long-range coupling toward the Hg(12). The chemical shifts of
the oligonucleotide moiety are summarized in Table S1B.
Electrospray Ionization Mass Spectrometry Method
Electrospray ionization mass spectra (ESI-MS) were recorded by Fin-
nigan LCQ ion-trap electrospray meter (LCQ-MS) in positive mode.
The employed voltage at the electrospray needles was 2.5 kV. The
capillary was heated to 150ºC. The solutions were injected into the
Nano-ESI source directly at the flow rate of 1.0 ml/min. Tandem
mass and zoom scan were used to analyze the structure of the prod-
uct. Helium gas was admitted directly into the ion trapping efficiency
and as collision gas in the collision-induced dissociation (CID) exper-
iment. A maximum ion injection time of 500 ms along with ten scans
was set. To induce collision activation, the relative collision energy
was controlled to 10%–30% of maximum, depending on the precur-
sor ions and the MSn. In MS/MS experiments, 6–12 isolation width for
the precursor ions were used to allow the Pt isotopic signature to be
observed.
Circular Dichroism Spectropolarimetry
The circular dichroism (CD) spectra were recorded in a JASCO J-600
Spectropolarimeter (Jasco, Corp., Tokyo, Japan). The pH of the so-
lutions was maintained in the range 6.9–7.4 by addition of NaOH so-
lution. Each spectrum was recorded at a wavelength range 190–250
nm in a 0.1 cm cuvette path length at room temperature under N2.
Spectra were baseline-corrected and noise-reduced with the Jasco
software.
Fluorescence Spectrophotometry
The fluorescence spectra were recorded in a Varian Cary Eclipse
fluorescence spectrophotometer equipped with a single-cell Peltier
accessory. Fluorescence spectra were recorded in the range of
295 to 450 nm with a scan rate of 120 nm/min. The maximum inten-
sity of the spectrum (at ca 362.9 and 358.9 nm for N-AcTrp and F2,respectively) was measured for each addition, and the association
constants for each system were obtained from the analysis of
Eadie-Hofstee plots [53]. Measurements were made at 20ºC, and re-
ported association constants (Ka) were averaged over a number of
six different experiments, with the significance of results compared
by using the unpaired t test.
Supplemental Data
Supplemental data include tables of 1H NMR chemical shift assign-
ments for the protein (Table S1A) and oligonucleotide (Table S1B)
moieties of d(TACGCC)-NCp7, ESI-MS spectra of 9-EtGH, 50-GMP
and trans-[PtCl(9-EtGH)(py)2]
+ with F2, N-AcTrp with Pt(dien)50-
GMP, and tandem MS for cis-[Pt(NH3)2(Guo)2]/F2 and may be found
at http://www.chembiol.com/cgi/content/full/13/5/539/DC1/.
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